MIM
KOD icon

MetLife Investment Management’s Kodiak Sciences KOD Stock Holding History

MetLife Investment Management’s Portfolio KOD Stock Details KOD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$776K Buy
20,363
+936
+5% +$24.2K ﹤0.01% 1528
2025
Q4 		$543K Hold
19,427
– – ﹤0.01% 1755
2025
Q3 		$318K Buy
+19,427
New +$167K ﹤0.01% 2046
2025
Q1 		– Sell
-21,040
Closed -$209K – 2806
2024
Q4 		$209K Buy
+21,040
New +$121K ﹤0.01% 2286
2024
Q2 		– Sell
-10,366
Closed -$54.5K – 2906
2024
Q1 		$54.5K Buy
+10,366
New +$50.8K ﹤0.01% 2703
2023
Q3 		– Sell
-18,141
Closed -$125K – 2935
2023
Q2 		$125K Hold
18,141
– – ﹤0.01% 2549
2023
Q1 		$112K Hold
18,141
– – ﹤0.01% 2498
2022
Q4 		$130K Hold
18,141
– – ﹤0.01% 2480
2022
Q3 		$140K Hold
18,141
– – ﹤0.01% 2496
2022
Q2 		$139K Hold
18,141
– – ﹤0.01% 2540
2022
Q1 		$140K Buy
18,141
+6,480
+56% +$253K ﹤0.01% 2540
2021
Q4 		$989K Hold
11,661
– – 0.01% 1131
2021
Q3 		$1.12M Sell
11,661
-924
-7% -$85.4K 0.01% 1069
2021
Q2 		$1.17M Hold
12,585
– – 0.01% 1086
2021
Q1 		$1.43M Sell
12,585
-754
-6% -$103K 0.01% 980
2020
Q4 		$1.96M Buy
13,339
+447
+3% +$49.8K 0.02% 829
2020
Q3 		$763K Hold
12,892
– – 0.01% 1161
2020
Q2 		$698K Buy
12,892
+795
+7% +$44.8K 0.01% 1197
2020
Q1 		$577K Buy
12,097
+1,752
+17% +$105K 0.01% 1136
2019
Q4 		$744K Sell
10,345
-2,243
-18% -$81.6K 0.01% 1247
2019
Q3 		$181K Hold
12,588
– – ﹤0.01% 2006
2019
Q2 		$147K Buy
+12,588
New +$112K ﹤0.01% 2202

Other funds holding KOD

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
BCM
Boxer Capital Management San Diego, California $762M AUM 1,125.36% 1-Year Est. Return

MetLife Investment Management's KOD Position: Q1 2026 in Review

MetLife Investment Management increased its Kodiak Sciences (KOD) stake by 4.8% in Q1 2026, buying an estimated $24.2K and bringing the position to 20,363 shares worth $776K. The position accounts for ﹤0.01% of the portfolio, ranked #1528.

MetLife Investment Management first reported a position in KOD in Q2 2019 and has held it in 22 quarters since. The position peaked at $1.96M in Q4 2020. 188 funds tracked by Wall St. Rank hold KOD as of Q1 2026.

  • MetLife Investment Management held 20,363 shares of Kodiak Sciences worth $776K as of Q1 2026.
  • MetLife Investment Management bought 936 Kodiak Sciences shares in Q1 2026, an estimated $24.2K.
  • Kodiak Sciences made up ﹤0.01% of MetLife Investment Management's portfolio in Q1 2026, its #1528 holding.
  • MetLife Investment Management first reported a position in Kodiak Sciences in Q2 2019 and has held it in 22 quarters since.
  • MetLife Investment Management's Kodiak Sciences position peaked at $1.96M in Q4 2020.
  • 188 funds tracked by Wall St. Rank held Kodiak Sciences as of Q1 2026.

Based on MetLife Investment Management's 13F filing for Q1 2026, filed 14 May 2026.